{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:10:25Z","timestamp":1785870625170,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ejphar.2010.05.003","type":"journal-article","created":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T08:48:07Z","timestamp":1274518087000},"page":"211-218","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation"],"prefix":"10.1016","volume":"640","author":[{"given":"Daniel S.","family":"Lorrain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Bain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia D.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Broadhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina M.","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia P.","family":"Prodanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice V.","family":"Darlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Zunic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Baccei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Stearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Roppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peppi","family":"Prasit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilly F.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.05.003_bib1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1084\/jem.185.6.1065","article-title":"Role of the 5-lipoxygenase-actiating protein (FLAP) in murine acute inflammatory response","volume":"185","author":"Byrum","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2010.05.003_bib2","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.4049\/jimmunol.163.12.6810","article-title":"Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory response using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice","volume":"163","author":"Byrum","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2010.05.003_bib3","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"Ciana","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2010.05.003_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0091-6749(95)70151-6","article-title":"The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo","volume":"95","author":"Diamont","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2010.05.003_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.it.2009.07.012","article-title":"Opening the flood-gates: how neutrophils-endothelial interactions regulate permeability","volume":"30","author":"DiStasi","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2010.05.003_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/343282a0","article-title":"Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis","volume":"343","author":"Dixon","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2010.05.003_bib7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0090-6980(85)90006-1","article-title":"Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2","volume":"30","author":"Doherty","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejphar.2010.05.003_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","article-title":"Treatment of asthma with drugs modifying the leukotriene pathway","volume":"340","author":"Drazen","year":"1999","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.ejphar.2010.05.003_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tips.2007.11.006","article-title":"What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases","volume":"29","author":"Evans","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2010.05.003_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaci.2004.12.1125","article-title":"Molecular mechanisms of anaphylaxis: lessons from studies with murine models","volume":"115","author":"Finkelman","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2010.05.003_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/286264a0","article-title":"Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes","volume":"286","author":"Ford-Hutchinson","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2010.05.003_bib12","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/S0960-894X(99)00399-6","article-title":"Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors","volume":"9","author":"Frenette","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2010.05.003_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/ajrccm\/147.4.839","article-title":"Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses","volume":"147","author":"Friedman","year":"1993","journal-title":"Am. Rev. Resp. Dis."},{"key":"10.1016\/j.ejphar.2010.05.003_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1139\/y89-073","article-title":"L-663, 536 (MK-886)(3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2, 2-dimethyl propanoic acid), a novel, orally active leukotriene biosynthesis inhibitor","volume":"67","author":"Gillard","year":"1989","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.05.003_bib15","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1073\/pnas.91.26.12852","article-title":"Altered inflammatory response in leukotriene-deficient mice","volume":"91","author":"Goulet","year":"1994","journal-title":"Proc. Natl Acad. Sci."},{"key":"10.1016\/j.ejphar.2010.05.003_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-291X(86)91215-5","article-title":"Leukotriene B4 (LTB4) production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells","volume":"137","author":"Gresele","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2010.05.003_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/thx.52.4.348","article-title":"Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005","volume":"52","author":"Hamilton","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2010.05.003_bib18","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.187.11.1779","article-title":"Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor","volume":"187","author":"Ishii","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2010.05.003_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y95-028","article-title":"Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist","volume":"73","author":"Jones","year":"1995","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.05.003_bib20","doi-asserted-by":"crossref","first-page":"22608","DOI":"10.1074\/jbc.M103562200","article-title":"Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase","volume":"276","author":"Kanaoka","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.05.003_bib21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1124\/jpet.109.158089","article-title":"Pharmacological characterization of AM103, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor reduces acute and chronic inflammation","volume":"331","author":"Lorrain","year":"2009","journal-title":"J. Pharm. Exp Ther."},{"key":"10.1016\/j.ejphar.2010.05.003_bib22","doi-asserted-by":"crossref","first-page":"20820","DOI":"10.1074\/jbc.M203163200","article-title":"Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses","volume":"277","author":"Maekawa","year":"2002","journal-title":"J. Bio. Chem."},{"key":"10.1016\/j.ejphar.2010.05.003_bib23","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1073\/pnas.0905364106","article-title":"GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4","volume":"106","author":"Maekawa","year":"2009","journal-title":"Proc. Natl Acad. Sci."},{"key":"10.1016\/j.ejphar.2010.05.003_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.23463","article-title":"5-Lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice","volume":"51","author":"Mart\u00ednez-Clement","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2010.05.003_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/BJ20070289","article-title":"Biosynthesis and metabolism of leukotrienes","volume":"405","author":"Murphy","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2010.05.003_bib26","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"Leukotrienes. N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2010.05.003_bib27","doi-asserted-by":"crossref","first-page":"C1028","DOI":"10.1152\/ajpcell.00658.2008","article-title":"Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTP\u03a5S binding and electrophysiological studies in 1321N1 cells","volume":"297","author":"Pugliese","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2010.05.003_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-3565(25)38889-0","article-title":"In vivo characterization of zymosan-induced mouse peritoneal inflammation","volume":"269","author":"Rao","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.05.003_bib29","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1124\/jpet.106.115436","article-title":"Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton","volume":"321","author":"Rao","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.05.003_bib30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2010.05.003_bib31","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0022-3565(25)12189-7","article-title":"Characterization of 5-lipoxygenase inhibitors in biochemical and functional in vivo assays","volume":"275","author":"Smith","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.05.003_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02263504","article-title":"The effects of 5-lipoxygenase inhibition on ascaris antigen (Ag)-induced responses in atopic monkeys","volume":"45","author":"Turner","year":"1996","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2010.05.003_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhdrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.ejphar.2010.05.003_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0223-5234(99)00225-1","article-title":"Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?","volume":"34","author":"Young","year":"1999","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2010.05.003_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0090-6980(85)90018-8","article-title":"Pharmacological investigation of the mechanisms of platelet activating factor induced mortality in the mouse","volume":"30","author":"Young","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejphar.2010.05.003_bib36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1099","article-title":"The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm","volume":"10","author":"Zao","year":"2004","journal-title":"Nat. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991000419X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991000419X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:55:32Z","timestamp":1740102932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991000419X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":36,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S001429991000419X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.05.003","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}